Low doses of transdermal buprenorphine in opioid-naive patients with cancer pain: a 4-week, nonrandomized, open-label, uncontrolled observational study.

PubWeight™: 0.83‹?›

🔗 View Article (PMID 19922884)

Published in Clin Ther on October 01, 2009

Authors

Sebastiano Mercadante, Gianpiero Porzio, Patrizia Ferrera, Federica Aielli, Lucilla Verna, Walter Tirelli, Patrizia Villari, Alessandra Casuccio

Articles by these authors

Use of opioid analgesics in the treatment of cancer pain: evidence-based recommendations from the EAPC. Lancet Oncol (2012) 3.26

Opioid prescription in Italy: new law, no effect. Lancet (2002) 2.01

Gabapentin for neuropathic cancer pain: a randomized controlled trial from the Gabapentin Cancer Pain Study Group. J Clin Oncol (2004) 1.95

High doses of oxycodone-naloxone combination may provide poor analgesia. Support Care Cancer (2011) 1.65

Current knowledge of buprenorphine and its unique pharmacological profile. Pain Pract (2010) 1.53

A five-year retrospective study of the epidemiological characteristics and visual outcomes of patients hospitalized for ocular trauma in a Mediterranean area. BMC Ophthalmol (2008) 1.49

Evaluation of esophageal motility using multichannel intraluminal impedance in healthy children and children with gastroesophageal reflux. J Pediatr Gastroenterol Nutr (2011) 1.49

The use of sublingual fentanyl for breakthrough pain by using doses proportional to opioid basal regimen. Curr Med Res Opin (2013) 1.47

Hiccup in patients with advanced cancer successfully treated with gabapentin: report of three cases. N Z Med J (2003) 1.47

Efficacy of periportal infiltration and intraperitoneal instillation of ropivacaine after laparoscopic surgery in children. J Laparoendosc Adv Surg Tech A (2009) 1.43

CT-guided neurolytic splanchnic nerve block by an anterior approach. J Pain Symptom Manage (2002) 1.39

One-year outcomes with new-generation multifocal intraocular lenses. Ophthalmology (2008) 1.35

Deep sclerectomy versus punch trabeculectomy with or without phacoemulsification: a randomized clinical trial. J Glaucoma (2004) 1.16

Physical exercise and quality of life in breast cancer survivors. Int J Med Sci (2008) 1.14

Palliative sedation in patients with advanced cancer followed at home: a systematic review. J Pain Symptom Manage (2011) 1.06

Residual vein thrombosis to establish duration of anticoagulation after a first episode of deep vein thrombosis: the Duration of Anticoagulation based on Compression UltraSonography (DACUS) study. Blood (2008) 1.05

Sustained-release oral morphine versus transdermal fentanyl and oral methadone in cancer pain management. Eur J Pain (2008) 1.04

Single nucleotide polymorphisms (SNPs) of pro-inflammatory/anti-inflammatory and thrombotic/fibrinolytic genes in patients with acute ischemic stroke in relation to TOAST subtype. Cytokine (2012) 1.04

Sleep disorders in advanced cancer patients: prevalence and factors associated. Support Care Cancer (2004) 1.03

KPC - 3 Klebsiella pneumoniae ST258 clone infection in postoperative abdominal surgery patients in an intensive care setting: analysis of a case series of 30 patients. BMC Anesthesiol (2013) 1.03

Deep sclerectomy versus trabeculectomy with low-dosage mitomycin C: four-year follow-up. Ophthalmologica (2008) 1.01

Surveillance of multidrug-resistant gram-negative bacilli in a neonatal intensive care unit: prominent role of cross transmission. Am J Infect Control (2007) 1.01

Frequency, indications, outcomes, and predictive factors of opioid switching in an acute palliative care unit. J Pain Symptom Manage (2009) 1.00

Episodic (breakthrough) pain prevalence in a population of cancer pain patients. Comparison of clinical diagnoses with the QUDEI--Italian questionnaire for intense episodic pain. J Pain Symptom Manage (2012) 0.99

Is ranibizumab effective in stopping the loss of vision for choroidal neovascularisation in pathologic myopia? A long-term follow-up study. Br J Ophthalmol (2010) 0.99

Aggressive pharmacological treatment for reversing malignant bowel obstruction. J Pain Symptom Manage (2004) 0.99

Addition of a second opioid may improve opioid response in cancer pain: preliminary data. Support Care Cancer (2004) 0.98

Optimization of opioid therapy for preventing incident pain associated with bone metastases. J Pain Symptom Manage (2004) 0.97

Peritoneal catheter for continuous drainage of ascites in advanced cancer patients. Support Care Cancer (2008) 0.97

Alternative treatments of breakthrough pain in patients receiving spinal analgesics for cancer pain. J Pain Symptom Manage (2005) 0.96

High-dose furosemide and small-volume hypertonic saline solution infusion for the treatment of leg edema in advanced cancer patients. J Pain Symptom Manage (2008) 0.96

The use of high doses of oxycodone in an acute palliative care unit. Am J Hosp Palliat Care (2010) 0.96

A model of acute symptom control unit: Pain Relief and Palliative Care Unit of La Maddalena Cancer Center. Support Care Cancer (2002) 0.96

Medical treatment for inoperable malignant bowel obstruction: a qualitative systematic review. J Pain Symptom Manage (2007) 0.95

Opioid escalation in patients with cancer pain: the effect of age. J Pain Symptom Manage (2006) 0.95

Intrathecal treatment in cancer patients unresponsive to multiple trials of systemic opioids. Clin J Pain (2007) 0.93

Cryptic Leishmania infantum infection in Italian HIV infected patients. BMC Infect Dis (2009) 0.93

The Supportive Care Task Force at the University of L'Aquila: 2-years experience. Support Care Cancer (2005) 0.92

Immuno-inflammatory predictors of stroke at follow-up in patients with chronic non-valvular atrial fibrillation (NVAF). Clin Sci (Lond) (2009) 0.92

Gabapentin in the treatment of hiccups in patients with advanced cancer: a 5-year experience. Clin Neuropharmacol (2010) 0.92

Controlled sedation for refractory symptoms in dying patients. J Pain Symptom Manage (2008) 0.91

Tapentadol in cancer pain management: a prospective open-label study. Curr Med Res Opin (2012) 0.91

Hyperalgesia: an emerging iatrogenic syndrome. J Pain Symptom Manage (2003) 0.91

Can malignant bowel obstruction in advanced cancer patients be treated at home? Support Care Cancer (2010) 0.91

Report of the clinical protocol committee: development of randomized trials for malignant bowel obstruction. J Pain Symptom Manage (2007) 0.91

The palliative prognostic score and survival in patients with advanced solid tumors receiving chemotherapy. Support Care Cancer (2007) 0.90

Pegylated liposomal doxorubicin with vinorelbine in metastatic breast carcinoma. A phase I-II clinical investigation. Oncology (2002) 0.90

E-PTFE (Gore-Tex) implant with or without low-dosage mitomycin-C as an adjuvant in penetrating glaucoma surgery: 2 year randomized clinical trial. Acta Ophthalmol (2007) 0.90

Safety and effectiveness of intravenous morphine for episodic (breakthrough) pain using a fixed ratio with the oral daily morphine dose. J Pain Symptom Manage (2004) 0.90

Patients' and relatives' perceptions about intravenous and subcutaneous hydration. J Pain Symptom Manage (2005) 0.89

Gabapentin in painful ophthalmoplegia. J Pain Symptom Manage (2002) 0.89

Efficacy and safety of deep, continuous palliative sedation at home: a retrospective, single-institution study. Support Care Cancer (2009) 0.89

Safety and effectiveness of intravenous morphine for episodic breakthrough pain in patients receiving transdermal buprenorphine. J Pain Symptom Manage (2006) 0.87

Opioid-induced or pain relief-reduced symptoms in advanced cancer patients? Eur J Pain (2006) 0.87

Peripheral frequency of CD4+ CD28- cells in acute ischemic stroke: relationship with stroke subtype and severity markers. Medicine (Baltimore) (2015) 0.87

Deep sclerectomy versus punch trabeculectomy: effect of low-dosage mitomycin C. Ophthalmologica (2005) 0.87

Rapid titration with intravenous morphine for severe cancer pain and immediate oral conversion. Cancer (2002) 0.87

Opioid switching from and to tapentadol extended release in cancer patients: conversion ratio with other opioids. Curr Med Res Opin (2013) 0.87